PRECISION IMMUNOTHERAPEUTICS LIMITED
ActiveKey figures
Like most small UK companies, PRECISION IMMUNOTHERAPEUTICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: PRECISION IMMUNOTHERAPEUTICS LIMITED
What kind of company is it?
PRECISION IMMUNOTHERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 11663294. It was incorporated on 6 Nov 2018. Its status is active. The registered office is in Newcastle upon tyne (NE20). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 30 Nov 2025); the company files micro-entity accounts. Net assets were −£20,339, down 246.7% on the previous year. Total assets were £125 and total liabilities £20,464. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By net assets it ranks lower than 76% of them (median £20,978). By total assets it ranks lower than 95% of them (median £125,654). By number of employees it ranks lower than 65% of them (median 1). It is older than 64% of them (median age 5.4 years).
Who runs and controls the company?
The company has 2 current directors. 3 persons with significant control are registered.
When are its next filings due?
The next accounts are due by 31 Aug 2027. The next confirmation statement is due by 5 Nov 2027.
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | — | — | — | — |
| Total assets | 722 | 951 | 1,455 | 47 | 125 |
| Total liabilities | — | — | 13,308 | 13,909 | 20,464 |
| Net assets / total equity | -28 | -7,449 | 11,853 | 13,862 | -20,339 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Research and experimental development on biotechnology
As described in the company's latest filed accounts.
History
19 events- CC SECRETARIES LIMITED resignedSecretary (corporate)
- Financial year 2024/25 endedAccounts: net assets −£20.3k, 0 employees
- Dr Alexander Self registered as a person with significant control
- Dr David Self registered as a person with significant control
- Mr Peter Self registered as a person with significant control
- Professor Colin Henry Self ceased to be a person with significant control
- Mr William Gwyn Cole ceased to be a person with significant control
- Financial year 2023/24 endedAccounts: net assets £13.9k, 0 employees
Earlier events (11)
- Financial year 2022/23 endedAccounts: net assets £11.9k, 0 employees
- Financial year 2021/22 endedAccounts: net assets −£7,449, 0 employees
- Financial year 2020/21 endedAccounts: net assets −£28, 0 employees
- Financial year 2019/20 endedAccounts: net assets £1
- Name changed to PRECISION IMMUNOTHERAPEUTICS LIMITEDPreviously PRECISION THERAPEUTICS LIMITED
- Declan Thomas CUNNINGHAM appointedDirector
- Colin Henry SELF appointedDirector
- CC SECRETARIES LIMITED appointedSecretary (corporate)
- Professor Colin Henry Self registered as a person with significant control
- Mr William Gwyn Cole registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.